Led by the Medicines and Healthcare products Regulatory Agency (MHRA) and Novartis, WP1 will have overall responsibility for establishing and running appropriate administrative, financial and project processes, as well as reporting on progress of the project to the IMI to ensure quality assurance of the project.

This work stream will be also responsible for internal and external communications strategy, to support interaction between WPs, and to publicise the outcomes and findings of the project ensuring maximum impact.

An essential function of WP1 will be to adapt and implement the sustainability strategy developed by the original WEB-RADR project.

 

Partners involved:

  • MHRA
  • Novartis